Brand Name(s): ReoPro
CAS nš: 143653-53-6
(ab-siks-ih-mab)
About Abciximab
This new site is dedicated exclusively to abciximab.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about abciximab on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.
This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total abciximab experience!
Why is this medication prescribed?
Abciximab is used to lessen the chance of heart attack in people who need percutaneous coronary intervention (PCI), a procedure to open blocked arteries of the heart.
A heart attack may occur when a blood vessel in the heart is blocked by a blood clot. Blood clots can sometimes form during PCI. Abciximab reduces the chance that a harmful clot will form by preventing certain cells in the blood from clumping together.
This medicine is regularly used with aspirin and heparin, which are other medicines used to keep the blood from clotting.
Latest News
Effects of GP IIb/IIIa Inhibitors on Vascular Inflammation, Coronary Microcirculation, and Platelet Function
The platelet glycoprotein (GP) IIb/IIIa inhibitors differ markedly in their pharmacokinetics,...
[more]Abciximab Helpful in Thrombosis During Intracranial Aneurysm Repair: Presented at RSNA
The glycoprotein IIb/IIIA platelet activation inhibitor abciximab (ReoPro) appears successful in...
[more]Medicure Announces New AGGRASTAT'R' Data at 2006 Scientific Sessions of the American Heart Association
Medicure Inc., a cardiovascular focused biopharmaceutical company, today announced that new data...
[more]The Benefits of abciximab with clopidogrel for percutaneous coronary intervention Questioned
Primary findings from the Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for...
[more]Abciximab Shows No Benefits in Emergency Stroke Treatment Trial: Presented at ESC
Abciximab shows no efficacy in the treatment of patients with acute ischaemic stroke, while it does...
[more]